<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32929008</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>39</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides.</ArticleTitle><Pagination><StartPage>24213</StartPage><EndPage>24223</EndPage><MedlinePgn>24213-24223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2008323117</ELocationID><Abstract><AbstractText>MicroRNAs (miRNAs) function cell-intrinsically to regulate gene expression by base-pairing to complementary mRNA targets while in association with Argonaute, the effector protein of the miRNA-mediated silencing complex (miRISC). A relatively dilute population of miRNAs can be found extracellularly in body fluids such as human blood plasma and cerebrospinal fluid (CSF). The remarkable stability of circulating miRNAs in such harsh extracellular environments can be attributed to their association with protective macromolecular complexes, including extracellular vesicles (EVs), proteins such as Argonaut 2 (AGO2), or high-density lipoproteins. The precise origins and the potential biological significance of various forms of miRNA-containing extracellular complexes are poorly understood. It is also not known whether extracellular miRNAs in their native state may retain the capacity for miRISC-mediated target RNA binding. To explore the potential functionality of circulating extracellular miRNAs, we comprehensively investigated the association between circulating miRNAs and the miRISC Argonaute AGO2. Using AGO2 immunoprecipitation (IP) followed by small-RNA sequencing, we find that miRNAs in circulation are primarily associated with antibody-accessible miRISC/AGO2 complexes. Moreover, we show that circulating miRNAs can base-pair with a target mimic in a seed-based manner, and that the target-bound AGO2 can be recovered from blood plasma in an &#x223c;1:1 ratio with the respective miRNA. Our findings suggest that miRNAs in circulation are largely contained in functional miRISC/AGO2 complexes under normal physiological conditions. However, we find that, in human CSF, the assortment of certain extracellular miRNAs into free miRISC/AGO2 complexes can be affected by pathological conditions such as amyotrophic lateral sclerosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Geekiyanage</LastName><ForeName>Hirosha</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7466-5983</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rayatpisheh</LastName><ForeName>Shima</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3388-5776</Identifier><AffiliationInfo><Affiliation>Department of Biological Chemistry, Geffen School of Medicine, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wohlschlegel</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, Geffen School of Medicine, University of California, Los Angeles, CA 90095.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambros</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605; victor.ambros@umassmed.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM131741</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM034028</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM088365</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C466422">AGO2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060565">Argonaute Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060565" MajorTopicYN="N">Argonaute Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020029" MajorTopicYN="N">Base Pairing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047468" MajorTopicYN="N">Immunoprecipitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AGO2</Keyword><Keyword MajorTopicYN="N">Argonaut</Keyword><Keyword MajorTopicYN="N">cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">extracellular microRNA</Keyword><Keyword MajorTopicYN="N">human plasma</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32929008</ArticleId><ArticleId IdType="pmc">PMC7533700</ArticleId><ArticleId IdType="doi">10.1073/pnas.2008323117</ArticleId><ArticleId IdType="pii">2008323117</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>He L., Hannon G. J., MicroRNAs: Small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522&#x2013;531 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15211354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambros V., MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing. Cell 113, 673&#x2013;676 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12809598</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D. P., MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281&#x2013;297 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosson A. D., Zamudio J. R., Sharp P. A., Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition. Mol. Cell 56, 347&#x2013;359 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5048918</ArticleId><ArticleId IdType="pubmed">25449132</ArticleId></ArticleIdList></Reference><Reference><Citation>Turchinovich A., Weiz L., Langheinz A., Burwinkel B., Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223&#x2013;7233 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167594</ArticleId><ArticleId IdType="pubmed">21609964</ArticleId></ArticleIdList></Reference><Reference><Citation>Arroyo J. D. et al. ., Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U.S.A. 108, 5003&#x2013;5008 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3064324</ArticleId><ArticleId IdType="pubmed">21383194</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevillet J. R. et al. ., Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc. Natl. Acad. Sci. U.S.A. 111, 14888&#x2013;14893 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4205618</ArticleId><ArticleId IdType="pubmed">25267620</ArticleId></ArticleIdList></Reference><Reference><Citation>Raoof R. et al. ., Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus. Sci. Rep. 7, 3328 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5468228</ArticleId><ArticleId IdType="pubmed">28607431</ArticleId></ArticleIdList></Reference><Reference><Citation>Geekiyanage H., Chan C., MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid &#x3b2;, novel targets in sporadic Alzheimer&#x2019;s disease. J. Neurosci. 31, 14820&#x2013;14830 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200297</ArticleId><ArticleId IdType="pubmed">21994399</ArticleId></ArticleIdList></Reference><Reference><Citation>Geekiyanage H., Jicha G. A., Nelson P. T., Chan C., Blood serum miRNA: Non-invasive biomarkers for Alzheimer&#x2019;s disease. Exp. Neurol. 235, 491&#x2013;496 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3361462</ArticleId><ArticleId IdType="pubmed">22155483</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z. et al. ., A novel serum microRNA signature to screen esophageal squamous cell carcinoma. Cancer Med. 6, 109&#x2013;119 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5269712</ArticleId><ArticleId IdType="pubmed">28035762</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Huang J., Liu J., Xu W., Yuan Z., Multivariate analysis of clinicopathological and prognostic significance of miRNA 106b&#x223c;25 cluster in gastric cancer. Cancer Cell Int. 19, 200 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664745</ArticleId><ArticleId IdType="pubmed">31384175</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C., Marzocchi C., Battistini S., MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells 7, 219 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward J. et al. ., Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis. Proc. Natl. Acad. Sci. U.S.A. 111, 12169&#x2013;12174 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4143020</ArticleId><ArticleId IdType="pubmed">25092309</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying W. et al. ., Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell 171, 372&#x2013;384.e12 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28942920</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers K. C., Palmisano B. T., Shoucri B. M., Shamburek R. D., Remaley A. T., MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423&#x2013;433 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3074610</ArticleId><ArticleId IdType="pubmed">21423178</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y. T. et al. ., Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum. Int. J. Mol. Med. 40, 834&#x2013;844 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5548045</ArticleId><ArticleId IdType="pubmed">28737826</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L. et al. ., Isolation and Identification of miRNAs in exosomes derived from serum of colon cancer patients. J. Cancer 8, 1145&#x2013;1152 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5463428</ArticleId><ArticleId IdType="pubmed">28607588</ArticleId></ArticleIdList></Reference><Reference><Citation>Prendergast E. N. et al. ., Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens. PLoS One 13, e0196913 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5940186</ArticleId><ArticleId IdType="pubmed">29738525</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Zhang S., Weber J., Baxter D., Galas D. J., Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248&#x2013;7259 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2978372</ArticleId><ArticleId IdType="pubmed">20615901</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X. et al. ., Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997&#x2013;1006 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18766170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell P. S. et al. ., Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513&#x2013;10518 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2492472</ArticleId><ArticleId IdType="pubmed">18663219</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. et al. ., Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39, 133&#x2013;144 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20603081</ArticleId></ArticleIdList></Reference><Reference><Citation>Zernecke A. et al. ., Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, ra81 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19996457</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbings D. J., Ciaudo C., Erhardt M., Voinnet O., Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 11, 1143&#x2013;1149 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19684575</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie A. J. et al. ., KRAS-MEK signaling controls Ago2 sorting into exosomes. Cell Rep. 15, 978&#x2013;987 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4857875</ArticleId><ArticleId IdType="pubmed">27117408</ArticleId></ArticleIdList></Reference><Reference><Citation>Horman S. R. et al. ., Akt-mediated phosphorylation of argonaute 2 downregulates cleavage and upregulates translational repression of microRNA targets. Mol. Cell 50, 356&#x2013;367 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3654076</ArticleId><ArticleId IdType="pubmed">23603119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohshima K. et al. ., Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 5, e13247 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951912</ArticleId><ArticleId IdType="pubmed">20949044</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomou T. et al. ., Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature 542, 450&#x2013;455 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5330251</ArticleId><ArticleId IdType="pubmed">28199304</ArticleId></ArticleIdList></Reference><Reference><Citation>Valadi H. et al. ., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654&#x2013;659 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17486113</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelbrunn M. et al. ., Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3104548</ArticleId><ArticleId IdType="pubmed">21505438</ArticleId></ArticleIdList></Reference><Reference><Citation>Skog J. et al. ., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470&#x2013;1476 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3423894</ArticleId><ArticleId IdType="pubmed">19011622</ArticleId></ArticleIdList></Reference><Reference><Citation>Max K. E. A. et al. ., Human plasma and serum extracellular small RNA reference profiles and their clinical utility. Proc. Natl. Acad. Sci. U.S.A. 115, E5334&#x2013;E5343 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6003356</ArticleId><ArticleId IdType="pubmed">29777089</ArticleId></ArticleIdList></Reference><Reference><Citation>Wee L. M., Flores-Jasso C. F., Salomon W. E., Zamore P. D., Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties. Cell 151, 1055&#x2013;1067 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3595543</ArticleId><ArticleId IdType="pubmed">23178124</ArticleId></ArticleIdList></Reference><Reference><Citation>Meltzer S. et al. ., Circulating exosomal miR-141-3p and miR-375 in metastatic progression of rectal cancer. Transl. Oncol. 12, 1038&#x2013;1044 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6542769</ArticleId><ArticleId IdType="pubmed">31146167</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S. et al. ., Differentially expressed miRNAs in circulating exosomes between atrial fibrillation and sinus rhythm. J. Thorac. Dis. 11, 4337&#x2013;4348 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6837955</ArticleId><ArticleId IdType="pubmed">31737319</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Pochampally R., Watabe K., Lu Z., Mo Y. Y., Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol. Cancer 13, 256 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4258287</ArticleId><ArticleId IdType="pubmed">25428807</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruel-Montoya R. et al. ., Differential miRNA expression profile and proteome in plasma exosomes from patients with paroxysmal nocturnal hemoglobinuria. Sci. Rep. 9, 3611 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6401143</ArticleId><ArticleId IdType="pubmed">30837665</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X. et al. ., Evaluation of tumor-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing. Clin. Cancer Res. 23, 5311&#x2013;5319 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28606918</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorski S. A., Vogel J., Doudna J. A., RNA-based recognition and targeting: Sowing the seeds of specificity. Nat. Rev. Mol. Cell Biol. 18, 215&#x2013;228 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28196981</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirle N. T., Sheu-Gruttadauria J., MacRae I. J., Structural basis for microRNA targeting. Science 346, 608&#x2013;613 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313529</ArticleId><ArticleId IdType="pubmed">25359968</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon W. E., Jolly S. M., Moore M. J., Zamore P. D., Serebrov V., Single-molecule imaging reveals that argonaute reshapes the binding properties of its nucleic acid guides. Cell 162, 84&#x2013;95 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4503223</ArticleId><ArticleId IdType="pubmed">26140592</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandradoss S. D., Schirle N. T., Szczepaniak M., MacRae I. J., Joo C., A dynamic search process underlies microRNA targeting. Cell 162, 96&#x2013;107 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4768356</ArticleId><ArticleId IdType="pubmed">26140593</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M. H. et al. ., Human argonaute 2 has diverse reaction pathways on target RNAs. Mol. Cell 59, 117&#x2013;124 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26140367</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirle N. T., MacRae I. J., The crystal structure of human argonaute2. Science 336, 1037&#x2013;1040 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3521581</ArticleId><ArticleId IdType="pubmed">22539551</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkayam E. et al. ., The structure of human argonaute-2 in complex with miR-20a. Cell 150, 100&#x2013;110 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3464090</ArticleId><ArticleId IdType="pubmed">22682761</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick J. A., Zamore P. D., Competitive endogenous RNAs cannot alter microRNA function in vivo. Mol. Cell 54, 711&#x2013;713 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24905003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterling C. H., Veksler-Lublinsky I., Ambros V., An efficient and sensitive method for preparing cDNA libraries from scarce biological samples. Nucleic Acids Res. 43, e1 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4288208</ArticleId><ArticleId IdType="pubmed">25056322</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams Z. et al. ., Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc. Natl. Acad. Sci. U.S.A. 110, 4255&#x2013;4260 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3600502</ArticleId><ArticleId IdType="pubmed">23440203</ArticleId></ArticleIdList></Reference><Reference><Citation>Turchinovich A., Tonevitsky A. G., Burwinkel B., Extracellular miRNA: A collision of two paradigms. Trends Biochem. Sci. 41, 883&#x2013;892 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27597517</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E. et al. ., Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23, 709&#x2013;717 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15908939</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffelers R. M. et al. ., Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32, e149 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC528817</ArticleId><ArticleId IdType="pubmed">15520458</ArticleId></ArticleIdList></Reference><Reference><Citation>Prud&#x2019;homme G. J., Glinka Y., Lichner Z., Yousef G. M., Neuropilin-1 is a receptor for extracellular miRNA and AGO2/miRNA complexes and mediates the internalization of miRNAs that modulate cell function. Oncotarget 7, 68057&#x2013;68071 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5356539</ArticleId><ArticleId IdType="pubmed">27486976</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation. Nature 454, 436&#x2013;444 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18650914</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Nedawi K. et al. ., Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10, 619&#x2013;624 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18425114</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler R. G., Pedersen W. A., Camandola S., Rothstein J. D., Mattson M. P., Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 52, 448&#x2013;457 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R. et al. ., Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front. Neurosci. 11, 731 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Benigni M. et al. ., Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients. Neuromolecular Med. 18, 551&#x2013;560 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27119371</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., M&#xfc;ller K., Ludolph A. C., Weishaupt J. H., Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 1, 42 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3893596</ArticleId><ArticleId IdType="pubmed">24252274</ArticleId></ArticleIdList></Reference><Reference><Citation>Jannot G., Vasquez-Rifo A., Simard M. J., Argonaute pull-down and RISC analysis using 2&#x2032;-O-methylated oligonucleotides affinity matrices. Methods Mol. Biol. 725, 233&#x2013;249 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21528458</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanriverdi K. et al. ., Comparison of RNA isolation and associated methods for extracellular RNA detection by high-throughput quantitative polymerase chain reaction. Anal. Biochem. 501, 66&#x2013;74 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26969789</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M. I., Huber W., Anders S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucukural A., Yukselen O., Ozata D. M., Moore M. J., Garber M., DEBrowser: Interactive differential expression analysis and visualization tool for count data. BMC Genom. 20, 6 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6321710</ArticleId><ArticleId IdType="pubmed">30611200</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>